| Product Code: ETC8134399 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Patented Drugs Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Patented Drugs Market - Industry Life Cycle |
3.4 Malaysia Patented Drugs Market - Porter's Five Forces |
3.5 Malaysia Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Malaysia Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Malaysia Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Malaysia Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Malaysia |
4.2.2 Growth in healthcare infrastructure and investments |
4.2.3 Favorable government policies supporting research and development in pharmaceuticals |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for patent approval |
4.3.2 High costs associated with patenting drugs and conducting clinical trials |
5 Malaysia Patented Drugs Market Trends |
6 Malaysia Patented Drugs Market, By Types |
6.1 Malaysia Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Malaysia Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Malaysia Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Malaysia Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Malaysia Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Malaysia Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Malaysia Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Malaysia Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Malaysia Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Malaysia Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Malaysia Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Malaysia Patented Drugs Market Import-Export Trade Statistics |
7.1 Malaysia Patented Drugs Market Export to Major Countries |
7.2 Malaysia Patented Drugs Market Imports from Major Countries |
8 Malaysia Patented Drugs Market Key Performance Indicators |
8.1 Number of new patents granted in the pharmaceutical sector |
8.2 Investment in research and development for patented drugs |
8.3 Number of collaborations between pharmaceutical companies and research institutions for drug development |
9 Malaysia Patented Drugs Market - Opportunity Assessment |
9.1 Malaysia Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Malaysia Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Malaysia Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Malaysia Patented Drugs Market - Competitive Landscape |
10.1 Malaysia Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here